Skip to content
Kalpvruksh Markets
Offline Log in

AKUMSNSEOffline

AKUMS DRUGS & PHARMA · INE09XN01023 · Small Cap · #637
744.60−6.90 (−0.92%)last close · 05 Nov 2026
Prev close
751.50
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹7,961 cr
52-week range · to 05 Nov 2026414.05823.3

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

AKUMS is 10% below its 52-week high, above its 200-day average — a Small Cap company, #637 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20 / 200-day averages · below its 50-day average · 10% below its 52-week high
  • +14.2% vs Nifty 500
  • traded value 2.0× usual · delivery 41% vs 51% usual
  • FPI +2.6 pp · DII −2.3 pp · MF schemes in Sept 2026: 5 bought, 7 cut · no promoter pledge · quarter ended 2026-09-30
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹7,961 cr
Rank
#637
Cap band
Small Cap
Nearest cut-off — Mid / Small
−76.72% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.3×
median 74,066
Delivered
92,984
Of volume
44%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+0.5%−5.1 pts—
1 month−8.6%−12.6 pts—
3 months+11.8%+14.2 pts—
6 months+34.9%+34.3 pts—
1 year+59.5%+63.7 pts—

Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+1.6%
above
vs 50-day average
−2.5%
below
vs 200-day average
+22.3%
above
ATR (14)
4.5%
typical daily range
Volatility
38%
1 month, annualised
Beta
1.01
vs Nifty 500, 1 year
Traded value
2.0×
vs usual
Delivery
41%
usual 51%
From the 52-week high
−9.6%
place in range 81% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters75.3%75.3%75.3%75.3%
FPI1.1%1.4% +0.21.9% +0.54.5% +2.6
Mutual funds11.2%10.9% −0.39.8% −1.27.6% −2.2
Other DII3.2%3.4% +0.23.7% +0.33.5% −0.2
Individuals5.5%5.3% −0.25.6% +0.25.2% −0.4
Others3.7%3.7%3.8% +0.23.9% +0.1

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 25 noneSep 25 noneDec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
67,618
Individuals
64,384

Indian passive funds’ stake

2026-06-30

Of free float
0.25%
Of all shares
0.06%
Schemes
9
Days to unwind
0.3
at 100% of volume

97,745 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
23
9 index · 14 active
Bought more
9
Sold some
6
FundSharesChangeDid
JioBlackRock Flexi Cap Fund(G)-Direct PlanActive+18,612+13.5%bought
Bandhan Small Cap Fund-Reg(G)Active+30,000+1.7%bought
ICICI Pru Healthcare Fund-(G)Active−2,86,639−11.6%sold
ICICI Pru Aggressive Hybrid Fund(G)Active−1,06,072−9.4%sold
Motilal Oswal Nifty Microcap 250 Index Fund-Reg(G)Index−8,410−8.1%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 26181461−7.3%₹779 cr
Aug 26182342−10.1%₹798 cr
Jul 26181282−14.0%₹752 cr
Jun 26190391−7.6%₹828 cr
May 26200240−7.6%₹754 cr
Apr 26202530+0.2%₹851 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Akums Drugs and Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
    03 Nov 2026
  • Board outcome
    Akums Drugs and Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    10 Aug 2026

AKUMS: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹1Final03 Jul 202603 Jul 2026
EarlierDividend₹2Special03 Jul 202603 Jul 2026

2 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.